Annual Operating Profit
-$61.72 M
-$1.55 M-2.57%
December 31, 2023
Summary
- As of February 7, 2025, SLN annual operating income is -$61.72 million, with the most recent change of -$1.55 million (-2.57%) on December 31, 2023.
- During the last 3 years, SLN annual operating profit has fallen by -$15.72 million (-34.16%).
- SLN annual operating profit is now -4091.17% below its all-time high of -$1.47 million, reached on December 31, 1995.
Performance
SLN Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$29.33 M
-$6.21 M-26.85%
September 1, 2024
Summary
- As of February 7, 2025, SLN quarterly operating income is -$29.33 million, with the most recent change of -$6.21 million (-26.85%) on September 1, 2024.
- Over the past year, SLN quarterly operating profit has dropped by -$12.81 million (-77.55%).
- SLN quarterly operating profit is now -456.32% below its all-time high of -$5.27 million, reached on March 31, 2024.
Performance
SLN Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$74.23 M
-$13.25 M-21.72%
September 1, 2024
Summary
- As of February 7, 2025, SLN TTM operating income is -$74.23 million, with the most recent change of -$13.25 million (-21.72%) on September 1, 2024.
- Over the past year, SLN TTM operating profit has dropped by -$12.53 million (-20.30%).
- SLN TTM operating profit is now -500.38% below its all-time high of -$12.36 million, reached on September 30, 2020.
Performance
SLN TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
SLN Operating Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -2.6% | -77.5% | -20.3% |
3 y3 years | -34.2% | -127.5% | -23.8% |
5 y5 years | -124.9% | -127.5% | -23.8% |
SLN Operating Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -2.6% | +2.1% | -456.3% | at low | -42.2% | at low |
5 y | 5-year | -112.6% | +2.1% | -456.3% | at low | -500.4% | at low |
alltime | all time | -4091.2% | +2.1% | -456.3% | at low | -500.4% | at low |
Silence Therapeutics Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$29.33 M(+26.9%) | -$74.23 M(+21.7%) |
Jun 2024 | - | -$23.12 M(+338.6%) | -$60.99 M(+16.8%) |
Mar 2024 | - | -$5.27 M(-68.1%) | -$52.21 M(-15.4%) |
Dec 2023 | -$61.72 M(+2.6%) | -$16.52 M(+2.7%) | -$61.70 M(+6.2%) |
Sep 2023 | - | -$16.08 M(+12.1%) | -$58.08 M(+0.1%) |
Jun 2023 | - | -$14.34 M(-2.9%) | -$58.03 M(-5.5%) |
Mar 2023 | - | -$14.77 M(+14.6%) | -$61.40 M(+2.4%) |
Dec 2022 | -$60.17 M(-4.5%) | -$12.89 M(-19.6%) | -$59.94 M(-3.7%) |
Sep 2022 | - | -$16.03 M(-9.5%) | -$62.24 M(-1.4%) |
Jun 2022 | - | -$17.71 M(+33.1%) | -$63.14 M(-0.6%) |
Mar 2022 | - | -$13.31 M(-12.3%) | -$63.50 M(+0.7%) |
Dec 2021 | -$63.03 M(+37.0%) | -$15.18 M(-10.4%) | -$63.07 M(-1.2%) |
Sep 2021 | - | -$16.94 M(-6.3%) | -$63.83 M(+7.7%) |
Jun 2021 | - | -$18.07 M(+40.3%) | -$59.26 M(+43.9%) |
Mar 2021 | - | -$12.88 M(-19.3%) | -$41.19 M(+45.5%) |
Dec 2020 | -$46.01 M(+58.5%) | -$15.95 M(+29.0%) | -$28.31 M(+129.0%) |
Sep 2020 | - | -$12.36 M | -$12.36 M |
Dec 2019 | -$29.03 M(+5.8%) | - | - |
Dec 2018 | -$27.45 M(+47.7%) | - | - |
Dec 2017 | -$18.58 M(+15.2%) | - | - |
Dec 2016 | -$16.13 M(+8.1%) | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2015 | -$14.93 M(-25.3%) | - | - |
Dec 2014 | -$19.99 M(+40.8%) | - | - |
Dec 2013 | -$14.19 M(+61.1%) | - | - |
Dec 2012 | -$8.81 M(+3.4%) | - | - |
Dec 2011 | -$8.52 M(-34.8%) | - | - |
Dec 2010 | -$13.07 M(+27.9%) | - | - |
Dec 2009 | -$10.22 M(-29.7%) | - | - |
Dec 2008 | -$14.54 M(+29.0%) | - | - |
Dec 2007 | -$11.28 M(+44.0%) | - | - |
Dec 2006 | -$7.83 M(+8.8%) | - | - |
Dec 2005 | -$7.19 M(+16.6%) | - | - |
Dec 2004 | -$6.17 M(+41.2%) | - | - |
Dec 2003 | -$4.37 M(+45.1%) | - | - |
Dec 2002 | -$3.01 M(-30.9%) | - | - |
Dec 2001 | -$4.36 M(+5.2%) | - | - |
Dec 2000 | -$4.15 M(+17.6%) | - | - |
Dec 1999 | -$3.53 M(+11.8%) | - | - |
Dec 1998 | -$3.15 M(-10.8%) | - | - |
Dec 1997 | -$3.54 M(+82.0%) | - | - |
Dec 1996 | -$1.94 M(+31.9%) | - | - |
Dec 1995 | -$1.47 M | - | - |
FAQ
- What is Silence Therapeutics annual operating income?
- What is the all time high annual operating profit for Silence Therapeutics?
- What is Silence Therapeutics annual operating profit year-on-year change?
- What is Silence Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Silence Therapeutics?
- What is Silence Therapeutics quarterly operating profit year-on-year change?
- What is Silence Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Silence Therapeutics?
- What is Silence Therapeutics TTM operating profit year-on-year change?
What is Silence Therapeutics annual operating income?
The current annual operating profit of SLN is -$61.72 M
What is the all time high annual operating profit for Silence Therapeutics?
Silence Therapeutics all-time high annual operating income is -$1.47 M
What is Silence Therapeutics annual operating profit year-on-year change?
Over the past year, SLN annual operating income has changed by -$1.55 M (-2.57%)
What is Silence Therapeutics quarterly operating income?
The current quarterly operating profit of SLN is -$29.33 M
What is the all time high quarterly operating profit for Silence Therapeutics?
Silence Therapeutics all-time high quarterly operating income is -$5.27 M
What is Silence Therapeutics quarterly operating profit year-on-year change?
Over the past year, SLN quarterly operating income has changed by -$12.81 M (-77.55%)
What is Silence Therapeutics TTM operating income?
The current TTM operating profit of SLN is -$74.23 M
What is the all time high TTM operating profit for Silence Therapeutics?
Silence Therapeutics all-time high TTM operating income is -$12.36 M
What is Silence Therapeutics TTM operating profit year-on-year change?
Over the past year, SLN TTM operating income has changed by -$12.53 M (-20.30%)